GSK and IQVIA Launch “Vaccine Track”
August 8, 2022
AVAC member GSK, in partnership with IQVIA, launched a new data trend platform to help improve adult vaccination in communities nationwide.
This is a first-of-its-kind platform provides publicly-accessible, quarterly data trends on adult vaccination to strengthen data transparency and empower the public health community with actionable information.
The Vaccine Track platform enables users to:
- Identify vaccination trends for adults 19+ in the US across multiple vaccines
- Scan immunization claims data nationally and sub-nationally across years
- Track trends based on 2019 pre-COVID-19 baseline vaccination uptake
- Highlight where differences exist based on demographics (e.g., age, race/ethnicity, gender, payer type)